Why Virtualize Clinical Trials?
About 10 percent of new drugs complete the first phase of a clinical trial but patient participation drops by 30
Read moreAbout 10 percent of new drugs complete the first phase of a clinical trial but patient participation drops by 30
Read moreClinical trials are often unsuccessful or incomplete due to the huge costs and other issues associated with recruitment and keeping
Read morePrescreening potential subjects in oncology clinical trials is one of the most significant limiting factors in identifying eligible participants which
Read moreThe goals of drug development process involves supporting all stakeholders in improving patient care, addressing challenges associated with financial sustainability
Read more